z-logo
open-access-imgOpen Access
Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014–2015 influenza season in Alberta, Canada
Author(s) -
Chaudhry Ahsan,
Bastien Nathalie,
Li Yan,
Scott Allison,
Pabbaraju Kanti,
Stewart Douglas,
Wong Sallene,
Drews Steven J.
Publication year - 2016
Publication title -
influenza and other respiratory viruses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.743
H-Index - 57
eISSN - 1750-2659
pISSN - 1750-2640
DOI - 10.1111/irv.12415
Subject(s) - oseltamivir , zanamivir , neuraminidase , neuraminidase inhibitor , virology , virus , influenza a virus , biology , microbiology and biotechnology , medicine , covid-19 , infectious disease (medical specialty) , disease
This manuscript describes the identification of an oseltamivir‐resistant influenza A (H3N2) virus in a respiratory specimen collected from an immunocompromised patient in Alberta, Canada, during the 2014–2015 influenza season. Following treatment with oseltamivir, neuraminidase ( NA ) gene sequencing indicated the presence of an R292K mutation. Phenotypic susceptibility testing by the NA ‐Star assay indicated a highly reduced inhibition by oseltamivir and normal inhibition by zanamivir. The use of zanamivir following identification of the oseltamivir‐resistant strain, combined with a partial immune reconstitution, was followed by a suggested decrease in the nasopharyngeal viral load in the nasopharynx and clinical improvement of the patient.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here